retatrutide maximum dose clinical trials produces up to 30.3% weight loss in Phase 3 trial VisualAbstract: Retatrutide reduces body weight

Experimental models show that Exenatide reduces hippocampal gliosis, improves serotonergic and GABAergic signaling, and alleviates behavioral disturbances, suggesting a pathway targeting inflammation, oxidative stress, and neurotransmitter imbalances [27]

Semaglutide may be inappropriate for people with label-listed contraindications, certain pregnancy or breastfeeding situations, or medical histories that raise concern for serious gastrointestinal, gallbladder, pancreatic, kidney, or mental health complications

Each vial contains 49.66mg net peptide, independently verified at 99.689% purity by Freedom Diagnostics (COA: 2603130116, Lot: RET40-2162026)

Our guide on retatrutide and hair loss covers this topic in detail, including prevention strategies

A 104-week extension reached 30.3%

Ethics declarations Competing interests R.D.G., I.K., P.J.C